Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis

Critical Care Medicine

Volumn 37, Issue 9, 2009, Pages 2619-2624

  Susa, Yasuyuki ^a   Masuda, Yoshiki ^a   Imaizumi, Hitoshi ^a   Namiki, Akiyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diaphragm contractility; HMGB1; Intra abdominal sepsis; Mitogen activated protein kinase; Oxygen derived free radical; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR ANTIBODY; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAPHRAGM; DIAPHRAGM DISEASE; DIAPHRAGM DYSFUNCTION; DIAPHRAGM MUSCLE; DOWN REGULATION; ENZYME PHOSPHORYLATION; LIPID PEROXIDATION; MALE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SEPSIS; SIGNAL TRANSDUCTION;

EID: 69349096408     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a930f7     Document Type: Article

References (25)

1. Wickel DJ, Cheadle WG, Mercer-Jones MA, et al: Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg 1997; 225:744-753
2. Mustard RA, Bohnen JM, Rosati C, et al: Pneumonia complicating abdominal sepsis: An independent risk factor for mortality. Arch Surg 1991; 126:170-175
3. Hussain SN: Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 1998; 179: 125-134
4. Boczkowski J, Dureuil B, Branger C, et al: Effects of sepsis on diaphragmatic function in rats. Am Rev Respir Dis 1988; 138: 260-265 (Pubitemid 18201879)
5. Fink MP, Heard SO: Laboratory models of sepsis and septic shock. J Surg Res 1990; 49:186-196 (Pubitemid 20241651)
6. Fujimura N, Sumita S, Aimono M, et al: Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med 2000; 162:2159-2165 (Pubitemid 32051680)
7. Fujimura N, Sumita S, Narimatsu E, et al: Alteration in diaphragmatic contractility during septic peritonitis in rats: Effect of polyethylene glycol-absorbed superoxide dismutase. Crit Care Med 2000; 28:2406-2414 (Pubitemid 30604446)
8. Taniguchi N, Kawahara K, Yone K, et al: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003; 48:971-981 (Pubitemid 36418239)
9. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251 (Pubitemid 29329996)
10. Kokkola R, Andersson A, Mullins G, et al: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61:1-9 (Pubitemid 40188342)
11. Liliensiek B, Weigand MA, Bierhaus A, et al: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004; 113:1641-1650 (Pubitemid 39071688)
12. Masuda Y, Sumita S, Fujimura N, et al: Geranylgeranylacetone attenuates septic diaphragm dysfunction by induction of heat shock protein 70. Crit Care Med 2003; 31: 2585-2591 (Pubitemid 37452837)
13. Susa Y, Masuda Y, Imaizumi H, et al: Role of high mobility group box-1 (HMGB1) in rats with lethal sepsis. Anesthesiology 2005; 103: A239
14. Tsung A, Sahai R, Tanaka H, et al: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201:1135-1143. Epub 2005 Mar 28 (Pubitemid 40524681)
15. Bustin M, Einck L, Reisch J, et al: Autoantibodies to nucleosomal proteins: Antibodies to HMG-17 in autoimmune disease. Science 1982; 215:1245-1247
16. Ueno H, Matsuda T, Hashimoto S, et al: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004; 170: 1310-1316 (Pubitemid 39657195)
17. Ulfgren AK, Grundtman G, Borg K, et al: Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum 2004; 50:1586-1594 (Pubitemid 38608081)
18. Shindoh C, Dimarco A, Nethery D, et al: Effect of PEG-superoxide dismutase on the diaphragmatic response to endotoxin. Am Rev Respir Dis 1992; 145:1350-1354
19. Hori O, Brett J, Slattery T, et al: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995; 270:25752-25761
20. Bucciarelli LG, Wendt T, Rong L, et al: RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease. Cell Mol Life Sci 2002; 59:1117-1128 (Pubitemid 34895406)
21. Degryse B, Bonaldi T, Scaffidi P, et al: The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152:1197-1206 (Pubitemid 34280177)
22. Sousa MM, Yan SD, Stern D, et al: Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest 2000; 80:1101-1110 (Pubitemid 30483229)
23. Lander HM, Taurus JM, Ogiste JS, et al: Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997; 272:17810-17814
24. Wautier MP, Chappey O, Corda S, et al: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280:E685-E694 (Pubitemid 32466835)
25. Eskandari MK, Bolgos G, Miller C, et al: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992; 148:2724-2730